1. If you haven’t yet, please check out our newly redesigned front page. We’ve updated it to include additional content, and to make existing content more accessible. In addition to the daily news headlines, industry social media posts and Seeking Alpha headlines, we’ve got the latest CP Wire articles, and the latest Pharmagather updates, which pulls together relevant industry blog posts. We’ll be adding additional features in the coming weeks.

Any new product releases?

Discussion in 'Bausch & Lomb' started by Anonymous, May 4, 2012 at 2:31 AM.

  1. Anonymous

    Anonymous Guest

    If there is going to be a reorganization holding mid-management accountable for product approvals may be prudent at this point in the game. Upper management has all been replaced recently. It is the mid-management that has been around for ages.

    If there are delays in product approvals this year it is time to look closely at mid-management. Did they make their timelines?

    If not it is time to do some serious thinking about restaffing mid-management.
  2. Anonymous

    Anonymous Guest

    Other than the name change to Development & Research there has been no real effort to shift more of the companies resources to development. So many people sitting on their -%$# and working on patents and publications but not contributing to the product development. No shift of resources and a poor team effort from the people currently in the research group for Development support leads to what we have. -- No product approvals from the FDA--
  3. Anonymous

    Anonymous Guest

    yep very soon. Will be a blockbuster.

Share This Page